TATI - Tübingen Ageing and Tumour Immunology Group
The Tübingen Ageing and Tumour Immunology Group (TATI) conducts research in human immunosenescence, vaccination, tumor immunity, immunotherapy, Alzheimer disease, longevity, immunity and aging. Our expertise is in polychromatic flow cytometry, T cell cloning, confocal microscopy, proteomics, signal transduction, hypoxia, antigen identification, immune monitoring, cancer vaccination, influenza vaccination.
Adriaensen W, Derhovanessian E, Vaes B, Van Pottelbergh G, Degryse JM, Pawelec G, Hamprecht K, Theeten H, Matheï C.
CD4:8 Ratio >5 Is Associated With a Dominant Naive T-Cell Phenotype and Impaired Physical Functioning in CMV-Seropositive Very Elderly People: Results From the BELFRAIL Study.
J Gerontol A Biol Sci Med Sci. 2014 Feb 25. [Epub ahead of print]
Faragher R, Frasca D, Remarque E, Pawelec G; for the ImAginE Consortium.
Better immunity in later life: a position paper.
Age (Dordr). 2014 Feb 16. [Epub ahead of print]
Pallis AG, Hatse S, Brouwers B, Pawelec G, Falandry C, Wedding U, Lago LD, Repetto L, Ring A, Wildiers H.
Evaluating the physiological reserves of older patients with cancer: The value of potential biomarkers of aging?
J Geriatr Oncol. 2013 Sep 29. pii: S1879-4068(13)00089-1. [Epub ahead of print]
Weide B, Martens A, Zelba H, Stutz C, Derhovanessian E, Di Giacomo AM, Maio M, Sucker A, Schilling B, Schadendorf D, Büttner P, Garbe C, Pawelec G.
Myeloid-derived suppressor cells predict survival of advanced melanoma patients: comparison with regulatory T cells and NY-ESO-1- or Melan-A-specific T cells.
Clin Cancer Res. 2013 Dec 9. [Epub ahead of print]
There is a complete list of the publication since 2012 of the TATI Group on the website.
Recent and Future Activities
Oct 8, 2013: Henning Zelba and Dr. B. Weide receive the prize for the Paper of the Year
of the Medical Faculty for their publication “Weide B, Zelba H, et al.: Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis. J Clin Oncol. 2012 May 20;30(15):1835-41.
Picture (C) Martin Schreier, firstname.lastname@example.org.
Oct 2013: G. Pawelec is invited speaker at the Cold Spring Harbor Asia Conferences.
The conference on Tumor Immunology and Immunotherapy takes place in Suzhou, China from October 28 to November 1, 2013.
Dec 17,2013: How to get your paper published.
Lecture at Athens University for the EU INtegrating the emerging research Potential of the University of Athens Cancer Research Group in the European research area (INsPiRE) project, Athens, 17th December, 2013 (invited by Prof. O. Tsitsiloni, in the red blazer in the pictures below).
Apr 27-30, 2014: CSC 2014 meeting in Rio das Pedras, Brazil.
G. Pawelec will be speaking at the CSC 2014 meeting.
Sept 24-26, 2014: PIVAC 2014 in Rome.
G. Pawelec is on the organising committee of the PIVAC 2014 Annual Meeting (First Announcement).
Oct 2-5, 2014: Bulgarian Immunology Society Triennial Congress in Varna.
G. Pawelec will be speaking at the Bulgarian Immunology Society Triennial Congress.
Oct 9-11, 2014: Annual NIBIT meeting, Siena.
G. Pawelec will be speaking at the Annual NIBIT meeting 2014.
Dec 1-4, 2014: BSI Annual Congress in Brighton.
G. Pawelec is organising the session "Immune frailty and defence against infections" at the BSI Annual Congress 2014.
G. Pawelec will be attending the following meetings in 2014:
AACR, San Diego, April;
CIMT, Mainz, May;
ASCO, Chicago, May;
FOCIS, Chicago, June;
GSA, Washington DC, November.